Hemodynamic Monitoring Systems Market Worth $1,167.4 Million by 2023

PUNE, India, August 20, 2018 /PRNewswire/ --

According to a new market research report "Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023", published by MarketsandMarkets™, the market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 91 market data Tables and 36 Figures spread through 149 Pages and in-depth TOC on "Hemodynamic Monitoring Systems Market"

https://www.marketsandmarkets.com/Market-Reports/hemodynamic-monitoring-systems-market-21684146.html

Early buyers will receive 10% customization on this report

The key factors driving the growth of this market are technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, rising geriatric population & growing number of surgeries, awareness initiatives by industry players, and government focus on critical care infrastructure & services.

By product, the disposables segment is expected to account for the largest share of the market in 2018 

On the basis of product, the global market is segmented into two broad categories monitors and disposables. In 2018, the disposables segment is expected to account for the largest share of the Hemodynamic Monitoring Systems Market owing to the presence of a large patient population undergoing diagnosis for vascular diseases; increasing adoption of disposables among medical professionals owing to their procedural and technological benefits; and ongoing technological advancements in catheters, probes, sensors, and guidewires. Furthermore, the rising incidence of risk factors for vascular diseases (such as obesity, hypertension, alcoholism, and diabetes) is also expected to support the growth of this market segment during the forecast period.